Synonyms: MILR1444A | RG3637 | TNX-650
Compound class:
Antibody
Comment: Lebrikizumab is a clinical candidate anti-IL-13 monoclonal antibody.
Peptide sequence and structural information for this antibody are available from its IMGT/mAb-db record. |
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
9165 | lebrikizumab |
Synonyms ![]() |
MILR1444A | RG3637 | TNX-650 |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 325 |
Other databases | |
GtoPdb PubChem SID | 223366019 |
Search PubMed clinical trials | lebrikizumab |
Search PubMed titles | lebrikizumab |
Search PubMed titles/abstracts | lebrikizumab |
Wikipedia | Lebrikizumab |